We may now know the real reason that Christine Blasey Ford has come forward to stop Brett Kavanaugh from joining the Supreme Court. She feels that it will affect her wallet. She has written or co-written 8 studies on the abortion pill, known as RU-486, which contains the ingredient mifepristone and is sold under the name of Korlym. It is the one and only product sold by Corcept Therapeutics. Ford works for Corcept Therapeutics and promotes Korlym. Should that product be outlawed by the Supreme Court, the company would likely be out of business. That seems like a very powerful incentive to keep a conservative off the bench.
Professor Christine Blasey Ford, while working for Stanford University, was also affiliated with Corcept Therapeutics (2006 – 2011). Her new Wikipedia page describes her as “director of biostatistics at Corcept.” Corcept Therapeutics Inc. (CORT) has a $1.66 billion market cap (worth), with current annual sales of $216 million.
Liberals and feminists are very worried that Judge Brett Kavanaugh may participate in reversing Roe v. Wade. Christine Blasey wants to stop Kavanaugh from reaching the country’s highest court.
According to an article at Philly.com, “ Alan Schatzberg, a Stanford University psychiatrist and scientist, co-founded Corcept Therapeutics in 1998 to explore whether mifepristone could help treat major depression.” He left the company in 2007, when the company changed direction (but continued to explore uses for mifepristone).
Korlym is also approved for people with the rare Cushing’s Syndrome.
Korlym is approved by the FDA for individuals with Cushing’s syndrome who also have type 2 diabetes (not diabetes only). Cushing’s Syndrome is a rare disease. Based on 2002 prevalence data, it was extrapolated (estimated) that there were 587 individuals with Cushing’s Syndrome in the USA. The article mentioned above describes 5000 individuals might be eligible for Korlym.